Health Canada - Government of Canada
Skip to left navigationSkip over navigation bars to content
About Health Canada

International Reporting

Bilateral and multilateral co-operation is an important way for Canada to address international drug activities. Health Canada is the competent authority for Canada's obligations as a signatory of three United Nations Drug Conventions: the Single Convention on Narcotic Drugs, the Convention on Psychotropic Substances, and the Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.

The federal partners of Canada's Drug Strategy participate in a variety of international working groups and bodies; as well as provide input into discussions and debates that take place in a variety of international fora. Canada has ongoing efforts with, and reporting to, key international organizations including the United Nations and the Organization of American States. Canada seeks and/or contributes to the development of knowledge at an international level on relevant issues, best practices, legislation, research and policy related to drug issues. Federal partners of CDS also provide training and education in an international context on policies, programs and promising practices in the area of substance use and abuse

Partners in CDS work with the United States through the Drug Enforcement Administration in the development of the Border Threat Assessment Report; report to the International Narcotics Control Board regarding the implementation of the three International Conventions to which Canada is signatory; contribute to the Multilateral Evaluation Mechanism and CICDAT Statistical Database of the OAS-CICAD, as well as contributing to the Annual Report Questionnaire and Biennial Report Questionnaire which are requirements of the UNODC.

Related Resources

Last Updated: 2006-05-15 Top